Sglt 2i CKD Farxiga denied for missing prior authorization by Cigna?

Cigna's specific coverage criteria for sglt2i ckd farxiga are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Cigna Requires Prior Authorization for Farxiga in CKD — and How to Navigate It

Prior authorization (PA) is not a denial of coverage — it is a process Cigna uses to confirm that a medication meets clinical and formulary criteria before the claim is paid. For dapagliflozin (Farxiga) prescribed for chronic kidney disease, Cigna typically requires documentation that the patient's diagnosis has been confirmed, that relevant clinical criteria are met, and sometimes that prior treatment steps have been completed. When a PA request is denied, or when the initial request was never submitted, it becomes a formal denial that you can appeal.

Understanding exactly what Cigna's PA criteria require — and ensuring the authorization request addresses every criterion explicitly — is the fastest path to approval. Most PA denials for dapagliflozin in CKD are resolved at the internal-appeal stage once the correct documentation is submitted.

### Why PA Denials Are Frequently Overturned

The most common cause of a PA denial is an incomplete or non-specific authorization request. The prescribing office may have submitted a generic request without attaching the chart documentation that satisfies each criterion. The appeal process allows you to resubmit with a complete, criterion-by-criterion documentation package — and it must be reviewed by a clinical reviewer not involved in the original decision.

### Federal Appeal Framework

• Internal appeal (ACA / ERISA §503): File within the deadline shown on the denial letter. You are entitled to a full-and-fair review. Request a reviewer with relevant specialty knowledge.
• External review (ACA §2719): If the internal appeal is denied, file for independent external review within approximately four months. The external reviewer's decision is binding on Cigna.
• Expedited review: If your condition is urgent and waiting would seriously jeopardize your health, both internal and external reviews can be expedited — typically 72-hour turnaround.

### Concrete Appeal Steps and Timeline

1. Obtain the denial letter. It must state the specific criterion or criteria not met — these become the checklist for your appeal. 2. Download Cigna's current PA criteria / clinical coverage policy for SGLT2 inhibitors in CKD from Cigna's website. 3. Pull the FDA-approved prescribing label for Farxiga to confirm the CKD indication. 4. Compile chart documentation that addresses each PA criterion: diagnosis, clinical course, prior treatments, and current clinical status. 5. Ask your prescriber (and nephrologist if involved) to write a medical-necessity letter that addresses each criterion by name with a supporting chart reference. 6. File the internal appeal before the deadline. If denied, file immediately for external review.

### Documentation to Gather

• CKD diagnosis records: Dated chart notes, specialist reports, and any relevant lab trend documentation your physician deems appropriate to include.
• Prior treatment history: Records of other kidney-protective or diabetes medications tried, with dates, durations, and outcomes.
• Clinical severity and trajectory: Physician notes documenting disease stage and progression relevant to the treatment decision.
• FDA label for Farxiga: Confirms the approved CKD indication being invoked.
• Prescriber letter: A detailed, signed letter mapping each Cigna PA criterion to a specific chart finding.

### Criteria-Mapping Structure

List every PA criterion from Cigna's published policy in order. For each, write the supporting chart fact with the document name and date. If a criterion involves a clinical value or threshold, your physician should state that the patient's values meet the relevant clinical guideline threshold — without the appeal letter itself asserting a specific number, which is the physician's responsibility to document.